Table of Contents
Chapter 1. Global Immunotherapy Drugs Market Executive Summary
1.1. Global Immunotherapy Drugs Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Application
1.3.3. By Route of Administration
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Immunotherapy Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Immunotherapy Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Technological advancements in antibody engineering
3.1.2. Rising demand for antibody therapies in clinical cancer treatment
3.1.3. Increasing need for personalized medicines and targeted therapies
3.2. Market Challenges
3.2.1. Stringent regulatory approval process
3.2.2. Complexities in development of antibody therapeutics
3.3. Market Opportunities
3.3.1. Increasing collaborations among pharmaceutical companies, CROs, CDMOs, and academic institutions
3.3.2. Expansion of immunotherapy applications in different therapeutic areas
3.3.3. Growth of immunotherapy research in emerging markets
Chapter 4. Global Immunotherapy Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Immunotherapy Drugs Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Immunotherapy Drugs Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Antibody Drugs
5.2.2. Inhibitor Drugs
5.2.3. Interferons and Interleukins
5.2.4. Cancer Vaccines
5.2.5. Other Types
Chapter 6. Global Immunotherapy Drugs Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Immunotherapy Drugs Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Cancer
6.2.2. Autoimmune and Inflammatory Diseases
6.2.3. Hematology
6.2.4. Osteology
6.2.5. Neurology
6.2.6. Other Applications
Chapter 7. Global Immunotherapy Drugs Market Size & Forecasts by Route of Administration 2022-2032
7.1. Segment Dashboard
7.2. Global Immunotherapy Drugs Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Intravenous
7.2.2. Subcutaneous
7.2.3. Other Routes of Administration
Chapter 8. Global Immunotherapy Drugs Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Global Immunotherapy Drugs Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals
8.2.2. Long-Term Care Facilities
8.2.3. Other End Users
Chapter 9. Global Immunotherapy Drugs Market Size & Forecasts by Region 2022-2032
9.1. North America Immunotherapy Drugs Market
9.1.1. U.S. Immunotherapy Drugs Market
9.1.1.1. Type breakdown size & forecasts, 2022-2032
9.1.1.2. Application breakdown size & forecasts, 2022-2032
9.1.1.3. Route of Administration breakdown size & forecasts, 2022-2032
9.1.1.4. End User breakdown size & forecasts, 2022-2032
9.1.2. Canada Immunotherapy Drugs Market
9.2. Europe Immunotherapy Drugs Market
9.2.1. U.K. Immunotherapy Drugs Market
9.2.2. Germany Immunotherapy Drugs Market
9.2.3. France Immunotherapy Drugs Market
9.2.4. Spain Immunotherapy Drugs Market
9.2.5. Italy Immunotherapy Drugs Market
9.2.6. Rest of Europe Immunotherapy Drugs Market
9.3. Asia-Pacific Immunotherapy Drugs Market
9.3.1. China Immunotherapy Drugs Market
9.3.2. India Immunotherapy Drugs Market
9.3.3. Japan Immunotherapy Drugs Market
9.3.4. Australia Immunotherapy Drugs Market
9.3.5. South Korea Immunotherapy Drugs Market
9.3.6. Rest of Asia Pacific Immunotherapy Drugs Market
9.4. Latin America Immunotherapy Drugs Market
9.4.1. Brazil Immunotherapy Drugs Market
9.4.2. Mexico Immunotherapy Drugs Market
9.4.3. Rest of Latin America Immunotherapy Drugs Market
9.5. Middle East & Africa Immunotherapy Drugs Market
9.5.1. Saudi Arabia Immunotherapy Drugs Market
9.5.2. South Africa Immunotherapy Drugs Market
9.5.3. Rest of Middle East & Africa Immunotherapy Drugs Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Merck & Co., Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Johnson & Johnson Services, Inc.
10.3.3. F. Hoffman-La Roche Ltd.
10.3.4. Pfizer Inc.
10.3.5. AstraZeneca
10.3.6. Novartis AG
10.3.7. Amgen Inc.
10.3.8. Gilead Sciences, Inc.
10.3.9. Bristol-Myers Squibb Company
10.3.10. Eli Lilly and Company
10.3.11. Sanofi
10.3.12. Takeda Pharmaceutical Company Limited
10.3.13. Teva Pharmaceutical Industries Ltd
10.3.14. GSK PLC
10.3.15. Abbvie Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes